ALB Albemarle Corporation

FY2025 10-K
Filed: Feb 11, 2026
Health Care
Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR

Albemarle Corporation (ALB) filed its fiscal year 2025 10-K annual report with the SEC on Feb 11, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business model: Global specialty chemicals company focused on lithium, bromine, and refining catalysts for energy storage and industrial markets
  • No new products or segments introduced; detailed emphasis on mineral resource classification and regulatory compliance under SEC subpart 1300
+3 more insights

Management Discussion & Analysis

  • Revenue $5.14B, down 4% YoY (-$234.8M); Energy Storage down 10% ($2.71B vs $3.02B), Specialties up 3% ($1.37B), Ketjen up 3% ($1.07B)
  • Gross profit margin 13.0% vs 1.2% in 2024; Operating margin data not explicitly stated
+4 more insights

Risk Factors

  • Ownership reduction at Wodgina lithium mine JV from 60% to 50% on October 18, 2023, impacting production share and control
  • Exposure to geopolitical risk in Jordan due to 50% JBC JV extracting bromine from Dead Sea under concession agreement expiring in 2058
+3 more insights

Financial Summary
XBRL

Revenue

$5.1B

Net Income

-$511M

Gross Margin

13.0%

Operating Margin

-7.1%

Net Margin

-9.9%

ROE

-5.4%

Total Assets

$16.4B

EPS (Diluted)

$-5.76

Operating Cash Flow

$1.3B

Source: XBRL data from Albemarle Corporation FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Albemarle Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available